Find An Allergist / Immunologist | Pollen Levels | Journal of Allergy and Clinical Immunology | Annual Meeting  
Contact    About AAAAI   

Search   
Meeting Home
Preliminary Program
Table of Contents
Educational Sessions
Download entire program (PDF)
Abstracts
Speakers
Industry/Exhibitors
Frequently Asked Questions
About San Antonio
Contact Us
AAAAI Home
 
 

Preliminary Program

Individual Daily Session Listings: Monday, March 21

The information listed here is accurate as of October 2004. For the most up-to-date session and speaker information, search the Online Itinerary Planner.

Seminars

4001 Aspirin Exacerbated Respiratory Disease 7:00 am to 8:00 am
4002 Pharmacotherapy for Asthma and Rhinitis in Pregnancy and Women of Childbearing Age 7:00 am to 8:00 am
4003 Management of Chronic Granulomatous Disease 7:00 am to 8:00 am
4004 Masqueraders of Common Autoimmune Diseases 7:00 am to 8:00 am
4005 Perioperative Anaphylaxis: Diagnosis and Management 7:00 am to 8:00 am
4006 Desensitization Protocols for Antibiotics and Other Medications 7:00 am to 8:00 am
4007 Adverse Reactions to Agents Used in Oncology 7:00 am to 8:00 am
4008 Voice Recognition Software: Is it Ready for Prime Time? 7:00 am to 8:00 am
4009 Safety Aspects of Immunotherapy 7:00 am to 8:00 am
4010 Chronic Rhinosinusitis: Update 7:00 am to 8:00 am
4011 Hygiene Hypothesis for Asthma: Pros and Cons 7:00 am to 8:00 am
4012 Eicosanoid Regulation of Allergic Disease 7:00 am to 8:00 am
4013 The Role of Neutrophils in Asthma 7:00 am to 8:00 am
4014 Th1-Th2: How Important-What are the Players? 7:00 am to 8:00 am
4015 Allergen-Derived Peptides: From Bench to Bedside 7:00 am to 8:00 am
4016 Clinically Important Allergens in Latin America 7:00 am to 8:00 am
4017 Environmental Triggers and Allergic Disease: Role of Innate Immunity and Potential Therapies 7:00 am to 8:00 am
4018 Developing Food Vehicles for DBPCFC-S 7:00 am to 8:00 am
4019 What is the Role of Genetic Research in Addressing Health Disparities? 7:00 am to 8:00 am
4020 Strengths and Weaknesses of Different Standardization 7:00 am to 8:00 am

Semi Plenary Sessions — NEW
4101 Optimizing Outcomes for Asthma 8:15 am to 9:45 am
4102 New Insights in Primary Immune Deficiencies 8:15 am to 9:45 am

Poster Sessions
  Authors Present: Poster sessions to be announced 9:45 am to 10:45 am

Presidential Symposium
4301 Difficult-to-Control Asthma: Lessons from the Literature 10:00 am to 12:00 pm


Symposia

4302 Mechanisms of Mediator Release from Inflammatory Cells 10:45 am to 12:00 pm
4303 Optimizing Management of Childhood Asthma 10:45 am to 12:00 pm
4305 Advances in Peanut Allergy 10:45 am to 12:00 pm
4306 Heterogeneity in Airway Diseases: Diagnostic and Therapeutic Implications 10:45 am to 12:00 pm
4307 The Expanding Roles of NK and NKT Cells 10:45 am to 12:00 pm
4308 Allergen Immunotherapy: Curative Vaccines for Allergy 10:45 am to 12:00 pm

Business Meeting
  AAAAI Business Meeting 12:15 pm to 1:30 pm

Oral Abstract Sessions
  Oral abstract sessions to be announced 1:30 pm to 2:45 pm

Workshops
4701 Bronchoprovocation Challenges: The How-To’s 3:00 pm to 4:30 pm
4702 Practical Aspects of Environmental Control for Asthma: When, Where and How 3:00 pm to 4:30 pm
4703 Advances in Allergen Standardization: Impact on Today’s Practice of Allergy 3:00 pm to 4:30 pm
4704 Challenging Cases in Insect Allergy 3:00 pm to 4:30 pm
4705 Drug Desensitization: Practical Approaches 3:00 pm to 4:30 pm
4706 Hands-On Rhinolaryngoscopy 3:00 pm to 4:30 pm
4707 Use of Multi-Media Presentation Graphics to Enhance Your Presentation (Intermediate) 3:00 pm to 4:30 pm
4708 Evaluation and Treatment of Asthma in Early Childhood 3:00 pm to 4:30 pm
4709 Non-IVIG Therapy of Primary Immunodeficiency 3:00 pm to 4:30 pm
4710 Challenging Ethical Dilemmas in Medical Research and Clinical
Care (in the 21st Century)
3:00 pm to 4:30 pm
4711 Allergenicity of Foods 3:00 pm to 4:30 pm
4712 Genetic Fingerprints and the Potential for Pharmacogenetics in the Treatment of Asthma 3:00 pm to 4:30 pm
4713 The Role of Innate Immune Responses in the Pathogenesis of Allergic Disease 3:00 pm to 4:30 pm
4714 Regulation of IgE Synthesis 3:00 pm to 4:30 pm
4715 What Makes Proteins Allergenic? 3:00 pm to 4:30 pm
4716 New Insights into Mast Cells 3:00 pm to 4:30 pm
4717 Regulatory Role of Ion Channels in the Activation of Immune Cells 3:00 pm to 4:30 pm
4718 Do Th1-type Cytokines Have a Role in Asthma? 3:00 pm to 4:30 pm
4719 Hot Topics in Allergy and Asthma: An Analytical Review of One Recent Landmark Publication 3:00 pm to 4:30 pm
4720 Update on ABAI Maintenance of Certification (MOC) Program 3:00 pm to 4:30 pm

Year-in-Review Session
4730 Year-in-Review: The Best of the JACI (Journal of Allergy and Clinical
Immunology)
3:00 pm to 4:30 pm

Dinner Symposia
4901 Selecting the Appropriate Antibiotic: Treatment of Community-Acquired
Respiratory Tract Infections (CARTIs)
6:30 pm to 8:30 pm
4902 Mild Asthma: To Treat or Not to Treat
6:30 pm to 8:30 pm
4903 Asthma: From Molecular Puzzle to Clinical Picture 6:30 pm to 8:30 pm

 

<back>



© 1996-2010 · All Rights Reserved · American Academy of Allergy Asthma & Immunology
Disclaimers and Contact Information · Site Map